Fink K - Search Results

1

Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach.

Shan C, Xie X, Zou J, Züst R, Zhang B, Ambrose R, Mackenzie J, Fink K, Shi PY. Shan C, et al. Among authors: fink k. J Virol. 2018 Oct 12;92(21):e01002-18. doi: 10.1128/JVI.01002-18. Print 2018 Nov 1. J Virol. 2018. PMID: 30111567 Free PMC article.

2

Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus control.

Fink K, Ng C, Nkenfou C, Vasudevan SG, van Rooijen N, Schul W. Fink K, et al. Eur J Immunol. 2009 Oct;39(10):2809-21. doi: 10.1002/eji.200939389. Eur J Immunol. 2009. PMID: 19637226 Free article.

3

Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection.

Balakrishnan T, Bela-Ong DB, Toh YX, Flamand M, Devi S, Koh MB, Hibberd ML, Ooi EE, Low JG, Leo YS, Gu F, Fink K. Balakrishnan T, et al. Among authors: fink k. PLoS One. 2011;6(12):e29430. doi: 10.1371/journal.pone.0029430. Epub 2011 Dec 22. PLoS One. 2011. PMID: 22216280 Free PMC article.

4

Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes.

Xu M, Hadinoto V, Appanna R, Joensson K, Toh YX, Balakrishnan T, Ong SH, Warter L, Leo YS, Wang CI, Fink K. Xu M, et al. Among authors: fink k. J Immunol. 2012 Dec 15;189(12):5877-85. doi: 10.4049/jimmunol.1201688. Epub 2012 Nov 14. J Immunol. 2012. PMID: 23152560

5

Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques.

Züst R, Dong H, Li XF, Chang DC, Zhang B, Balakrishnan T, Toh YX, Jiang T, Li SH, Deng YQ, Ellis BR, Ellis EM, Poidinger M, Zolezzi F, Qin CF, Shi PY, Fink K. Züst R, et al. Among authors: fink k. PLoS Pathog. 2013;9(8):e1003521. doi: 10.1371/journal.ppat.1003521. Epub 2013 Aug 1. PLoS Pathog. 2013. PMID: 23935499 Free PMC article.

6

Activation of peripheral blood mononuclear cells by dengue virus infection depotentiates balapiravir.

Chen YL, Abdul Ghafar N, Karuna R, Fu Y, Lim SP, Schul W, Gu F, Herve M, Yokohama F, Wang G, Cerny D, Fink K, Blasco F, Shi PY. Chen YL, et al. Among authors: fink k. J Virol. 2014 Feb;88(3):1740-7. doi: 10.1128/JVI.02841-13. Epub 2013 Nov 20. J Virol. 2014. PMID: 24257621 Free PMC article.

7

Live attenuated vaccine: the first clinically approved dengue vaccine?

Fink K, Shi PY. Fink K, et al. Expert Rev Vaccines. 2014 Feb;13(2):185-8. doi: 10.1586/14760584.2014.870888. Epub 2013 Dec 18. Expert Rev Vaccines. 2014. PMID: 24350687 Free article.

8

Flavivirus RNA methylation.

Dong H, Fink K, Züst R, Lim SP, Qin CF, Shi PY. Dong H, et al. Among authors: fink k. J Gen Virol. 2014 Apr;95(Pt 4):763-778. doi: 10.1099/vir.0.062208-0. Epub 2014 Jan 31. J Gen Virol. 2014. PMID: 24486628 Review.

9

Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.

Züst R, Toh YX, Valdés I, Cerny D, Heinrich J, Hermida L, Marcos E, Guillén G, Kalinke U, Shi PY, Fink K. Züst R, et al. Among authors: fink k. J Virol. 2014 Jul;88(13):7276-85. doi: 10.1128/JVI.03827-13. Epub 2014 Apr 16. J Virol. 2014. PMID: 24741106 Free PMC article.

10

Selective susceptibility of human skin antigen presenting cells to productive dengue virus infection.

Cerny D, Haniffa M, Shin A, Bigliardi P, Tan BK, Lee B, Poidinger M, Tan EY, Ginhoux F, Fink K. Cerny D, et al. Among authors: fink k. PLoS Pathog. 2014 Dec 4;10(12):e1004548. doi: 10.1371/journal.ppat.1004548. eCollection 2014 Dec. PLoS Pathog. 2014. PMID: 25474532 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

646 results

Search Page

Filters